Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
94
Recruiting, any sponsor type, condition "acute pain"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed825
94 trials
Showing 1 to 25, recently updated first.
- Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children.Pivotal-lookingRecruiting
Fondation LenvalAcademic, hospital or other
NCT06968546 · 116 participants (planned) · Start May 14, 2026 · Primary completion Mar 31, 2028
Drug: Intranasal Sufentanil; Intranasal Ketamine (IN) · For: Traumatology; Wounds and Injury; Fractures Bone and 4 more
Sites: Nice, France
- A Clinical Trial of MK-6916 in Participants With Pain After Bunion Removal Surgery (MK-6916-007)Pivotal-lookingRecruiting
Merck Sharp & Dohme LLCMerck & Co. (MRK)
NCT07862595 · 380 participants (planned) · Start Nov 2, 2026 · Primary completion Jun 10, 2027
Drug: MK-6916; Hydrocodone/acetaminophen (HB/APAP) and 2 more · For: Pain Management
Sites: Miami, Florida; Tampa, Florida; Atlanta, Georgia · 9 sites in all
Wake Forest University Health SciencesAcademic, hospital or other
NCT07409753 · 60 participants (planned) · Start Oct 22, 2025 · Primary completion Jun 1, 2027
Drug: Intravenous Oxytocin; Intravenous Placebo · For: Acute Pain
Sites: Linköping, Sweden
- Effect of S-Ibuprofen Gel on Pain in Acute Soft Tissue ContusionsPivotal-lookingRecruiting
Aponia Laboratories, Inc.Industry
NCT07930559 · 240 participants (planned) · Start Oct 8, 2026 · Primary completion Jun 2027
Drug: S-Ibuprofen Gel 5%; Vehicle Topical Gel · For: Acute Pain Due to Trauma
Sites: Bend, Oregon; Bonn, Germany; Gilching, Germany · 6 sites in all
- REctus Sheath TrialRecruiting
Duke UniversityAcademic, hospital or other
NCT07068243 · 25 participants (planned) · Start Oct 26, 2026 · Primary completion Feb 2027
Drug: 1.0% lidocaine with epinephrine (1:100,000) · For: Acute Pain; Postoperative Pain, Acute
Sites: Durham, North Carolina
- Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary SyndromePivotal-lookingRecruiting
Gyeongsang National University HospitalAcademic, hospital or other
NCT07684742 · 2,200 participants (planned) · Start Jul 1, 2026 · Primary completion Jul 1, 2031
Drug: Early P2Y12 Inhibitor Monotherapy; Standard Dual Antiplatelet Therapy · For: Acute Coronary Syndromes; STEMI; NSTEMI and 1 more
Sites: Jinju, South Korea
- Assessment of the Value of FAPI and FDG-PET-CT in Diagnosis of Acute Phase Peyronie's DiseaseRecruiting
University Medical Center GroningenAcademic, hospital or other
NCT07903987 · 20 participants (planned) · Start Dec 13, 2024 · Primary completion Aug 30, 2027
Drug: 68Ga-FAPI (gallium-68-labeled fibroblast activation protein inhibitor) · For: Peyronie's Disease
Sites: Nieuwegein, Netherlands
Cytogel Pharma, LLCIndustry
NCT07905105 · 32 participants (planned) · Start Sep 25, 2026 · Primary completion Oct 2027
Drug: CYT-1010; Placebo · For: Acute Postoperative Pain; Dental Pain
Sites: Salt Lake City, Utah
- Optimizing Pain Treatment in Children On Mechanical VentilationPivotal-lookingRecruiting
Weill Medical College of Cornell UniversityAcademic, hospital or other
NCT06994442 · 644 participants (planned) · Start Dec 29, 2025 · Primary completion Jul 31, 2029
Drug: Acetaminophen; Ketorolac and 1 more · For: Mechanical Ventilation; Pediatric Acute Respiratory Failure; Analgesics, Opioid and 1 more
Sites: Little Rock, Arkansas; Washington D.C., District of Columbia; Ann Arbor, Michigan · 16 sites in all
Asklepios Kliniken Hamburg GmbHAcademic, hospital or other
NCT07099924 · 40 participants (planned) · Start Oct 6, 2025 · Primary completion Aug 2027
Drug: Ropivacaine 0.2%; Saline 0.9% · For: Acute Abdomen; Ileus; Colorectal Carcinoma
Sites: Schwedt, Germany
University of Maryland, BaltimoreAcademic, hospital or other
NCT03446456 · 56 participants (planned) · Start Sep 17, 2018 · Primary completion Dec 31, 2026
Drug: Arginine vasopressin · For: Acute Pain
Sites: Baltimore, Maryland
- Postoperative Delirium and Analgesia in Elderly PatientsPivotal-lookingRecruiting
Ankara City Hospital BilkentAcademic, hospital or other
NCT07849517 · 300 participants (planned) · Start Oct 1, 2026 · Primary completion May 25, 2027
Drug: adductor canal block and biFes block including bupivacain; Periarticular infiltration · For: Postoperative Delirium; Postoperative Pain, Acute
Sites: Ankara, Turkey (Türkiye)
- An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical OriginPivotal-lookingRecruiting
Adneuris Therapeutics, Inc.Industry
NCT07845071 · 160 participants (planned) · Start Sep 22, 2026 · Primary completion Jan 2027
Drug: Cebranopadol 400 ug · For: Pain
Sites: Phoenix, Arizona; Riverside, California; Longmont, Colorado · 15 sites in all
- Morphine or Ketamine for AnalgesiaPivotal-lookingRecruiting
Columbia UniversityAcademic, hospital or other
NCT06835504 · 1,010 participants (planned) · Start Oct 17, 2026 · Primary completion Apr 23, 2030
Drug: Ketamine hydrochloride; Morphine sulphate · For: Abdominal Pain; Isolated Extremity Fracture; Pain and 1 more
Sites: Los Angeles, California; Sacramento, California; Wilmington, Delaware · 8 sites in all
- Perioperative Multimodal Analgesia for Supratentorial CraniotomyPivotal-lookingRecruiting
Beijing Tiantan HospitalAcademic, hospital or other
NCT07441421 · 2,000 participants (planned) · Start Mar 9, 2026 · Primary completion Dec 31, 2027
Drug: Dexmedetomidine · For: Postoperative Pain; Analgesia; Supratentorial Brain Tumor
Sites: Beijing, China
Northwell HealthAcademic, hospital or other
NCT06379425 · 70 participants (planned) · Start Mar 1, 2024 · Primary completion Jan 1, 2027
Drug: Acetaminophen; Celecoxib and 1 more · For: Pain, Postoperative; Postoperative Pain, Acute
Sites: Bay Shore, New York
Vasiliki SamartziAcademic, hospital or other
NCT07846722 · 90 participants (planned) · Start Jul 15, 2026 · Primary completion Dec 1, 2026
Drug: Esmolol hydrochloride; Dexmedetomidine and 1 more · For: Pain, Acute Post-Operative; Dexmedetomidine; Analgesia and 3 more
Sites: Athens, Greece
Jiangsu HengRui Medicine Co., Ltd.Industry
NCT06344091 · 232 participants (planned) · Start May 21, 2024 · Primary completion May 2027
Drug: Bupivacaine Liposome Injection · For: Local Analgesia Via Infiltration
Sites: Guangzhou, China
- Comparison of the Efficacy and Safety of Intravenous Buprenorphine Administered Via PCA System Versus Oxycodone in the Management of Postoperative Pain After Video-Assisted Thoracoscopic SurgeryPivotal-lookingRecruiting
Medical University of SilesiaAcademic, hospital or other
NCT07434427 · 200 participants (planned) · Start Mar 18, 2026 · Primary completion May 2027
Drug: Group B (Buprenorphine); Group O (Oxycodone) · For: Acute Postoperative Pain; Chronic Postoperative Pain; Toracosurgery and 1 more
Sites: Zabrze, Poland
- Anterior Suprascapular Versus Interscalene Block for Postoperative Analgesia After Arthroscopic Shoulder Surgery in the Outpatient SettingPivotal-lookingRecruiting
ASST Sette LaghiAcademic, hospital or other
NCT07831096 · 100 participants (planned) · Start Jan 16, 2026 · Primary completion Feb 2027
Drug: Ropivacaine · For: Postoperative Pain, Acute
Sites: Varese, Italy
- Effect Of Specimen Extraction Site And Local Anesthesia On Postoperative Pain In Laparoscopic AppendectomyPivotal-lookingRecruiting
YUNUS YÜKSELAcademic, hospital or other
NCT07824908 · 300 participants (planned) · Start Apr 24, 2026 · Primary completion Dec 1, 2026
Drug: Port-site local anesthesia infiltration · For: Appendectomy, Laparoscopic; Appendicitis Acute; Pain Management
Sites: Diyarbakır, Turkey (Türkiye)
- Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary SyndromePivotal-lookingRecruiting
Taipei Medical University HospitalAcademic, hospital or other
NCT07824323 · 400 participants (planned) · Start Aug 26, 2026 · Primary completion Mar 2028
Drug: bempedoic acid; Ezetimibe and 1 more · For: Acute Coronary Syndromes; Dyslipidemia
Sites: Taipei, Taiwan
- A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute PainPivotal-lookingRecruiting
AFT Pharmaceuticals, Ltd.Industry
NCT07225634 · 60 participants (planned) · Start Sep 14, 2026 · Primary completion Mar 2027
Drug: Combogesic® IV (fixed-dose combination containing acetaminophen 10 mg/ml + ibuprofen 3 mg/ml in 100 ml solution for infusion) · For: Acute Pain
Sites: Budapest, Hungary; Győr, Hungary; Pécs, Hungary · 4 sites in all
- Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the EDPivotal-lookingRecruiting
Antonios LikourezosAcademic, hospital or other
NCT06364540 · 150 participants (planned) · Start May 1, 2024 · Primary completion Jun 30, 2027
Drug: Ketamine; Fentanyl · For: Pain, Acute
Sites: Brooklyn, New York
Hospital Universitari de BellvitgeAcademic, hospital or other
NCT06851910 · 20 participants (planned) · Start Apr 21, 2025 · Primary completion Dec 2027
Drug: Lacosamide · For: Trigeminal Neuralgia
Sites: L'Hospitalet de Llobregat, Spain
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.